Targeting NF-κB pathway by dietary lignans in inflammation: expanding roles of gut microbiota and metabolites

Crit Rev Food Sci Nutr. 2023;63(22):5967-5983. doi: 10.1080/10408398.2022.2026871. Epub 2022 Jan 24.

Abstract

Inflammation is a major factor affecting human health. Nuclear factor-kappa B (NF-κB) plays a vital role in the development of inflammation, and the promoters of most inflammatory cytokine genes have NF-κB-binding sites. Targeting NF-κB could be an exciting route for the prevention and treatment of inflammatory diseases. As important constituents of natural plants, lignans are proved to have numerous biological functions. There are growing pieces of evidence demonstrate that lignans have the potential anti-inflammatory activities. In this work, the type, structure and source of lignans and the influence on mitigating the inflammation are systematically summarized. This review focuses on the targeting NF-κB signaling pathway in the inflammatory response by different lignans and their molecular mechanisms. Lignans also regulate gut microflora and change gut microbial metabolites, which exert novel pathway to prevent NF-κB activation. Taken together, lignans target NF-κB with various mechanisms to inhibit inflammatory cytokine expressions in the inflammatory response. It will provide a scientific theoretical basis for further research on the anti-inflammatory effects of lignans and the development of functional foods.

Keywords: Gut microbiota; NF-κB; inflammation; lignans; signaling pathway.

Publication types

  • Review

MeSH terms

  • Anti-Inflammatory Agents / pharmacology
  • Anti-Inflammatory Agents / therapeutic use
  • Cytokines
  • Gastrointestinal Microbiome*
  • Humans
  • Inflammation / drug therapy
  • Inflammation / metabolism
  • Lignans* / pharmacology
  • NF-kappa B / metabolism

Substances

  • NF-kappa B
  • Lignans
  • Cytokines
  • Anti-Inflammatory Agents